| COMPANY |
Bolt Biotherapeutics, Inc. |
| COURT |
United States District Court for the Northern District of California |
| CASE NUMBER |
24-cv-03985 |
| JUDGE |
The Hon. Jacqueline Scott Corley |
| CLASS PERIOD |
February 5, 2021 through May 14, 2024 |
| SECURITY TYPE |
Securities |
LEAD PLAINTIFF DEADLINE IS SEPTEMBER 3, 2024.
If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.
Case Background:
The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) BDC-1001, Bolt’s immune-stimulating antibody conjugate designed to target a tumor antigen known as human epidermal growth factor receptor 2 that is often found in cancers such as breast and gastroesophageal cancer, was less effective than the company had represented to investors and was in fact unlikely to meet its pre-defined success criteria; (2) accordingly, Defendants overstated the clinical and/or commercial prospects of Bolt’s product pipeline, on which the company primarily relies to sustain its business model; (3) all of the foregoing subjected the company to a heightened risk of disruptive leadership transitions and substantial workforce reduction; and (4) as a result, the company’s public statements were materially false and misleading at all relevant times.
What is a Lead Plaintiff?
A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.